Wednesday, October 17, 2018

Avidity Biosciences Gets Funding For Muscular Dystrophy Therapy

La Jolla-based Avidity Biosciences, a biopharmaceuticals startup developing treatments with Duchenne muscular dystrophy (DMD), says it has received an equity investment in the firm. The investment came from CureDuchenne, the nonprofit which is focused on finding a cure to DMD. Size of the funding was not announced. Avidity Biosciences is developing pr

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.